
Lingraphica Device Assessment
Medical
Free
iPad
The Lingraphica Device Assessment Tool gives speech-language pathologists the ability to assess multiple clients’ readiness for a Lingraphica speech-generating device. By working through three simple sections (an Evaluation, a Device Simulation, and a Questionnaire), a speech-language pathologist can determine if a client has the necessary skills and functionality needed to operate a Lingraphica speech-generating device. The app is designed with flexibility in mind, so speech-language pathologists can use it to evaluate multiple patients anywhere and anytime. Upon completion of the assessment, a speech-language pathologist can view and send the results to Lingraphica and receive a free clinical consultation.
How it Works:
Speech-language pathologists using the app to assess clients will progress through three sections:
•Evaluation
•Device Simulation
•Questionnaire
Download it for free:
Speech-language pathologists can download the app and use it to evaluate clients at anytime. No in-app purchases are required.
This app has been updated by Apple to display the Apple Watch app icon.
- Bug fixes were made.
- Results can now be submitted to Lingraphica directly without needing an email address.
The developer, Lingraphicare, Inc., has not provided details about its privacy practices and handling of data to Apple. For more information, see the developer’s privacy policy.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Lingraphicare, Inc.
- Size
- 156.8 MB
- Category
- Medical
- Compatibility
Requires iPadOS 8.0 or later.
- iPad
Requires iPadOS 8.0 or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
- English
- Age Rating
13+
- 13+
- Infrequent
Medical Treatment information
Alcohol, Tobacco, Drug Use or References
- Copyright
- © 2017, Lingraphicare America, Inc.